Department of Surgery, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, CA, USA.
Department of Radiology, Division of Radiation Oncology, Harbor-UCLA Medical Center, Torrance, CA, USA.
Am Surg. 2021 May;87(5):833-838. doi: 10.1177/0003134820956351. Epub 2020 Nov 24.
Intraoperative radiotherapy (IORT) can allow for single-dose radiation treatment following breast conservation therapy in low-risk patients with early breast cancer, in lieu of a traditional 6-week course of whole breast radiotherapy (WBRT). The objective of this study was to analyze the uptake and utilization of an IORT program in a safety-net hospital.
A retrospective review was conducted for all patients who underwent IORT from September 2014 to June 2018. Patient demographics, tumor characteristics, and IORT outcomes were analyzed. The proportion of patients undergoing IORT were determined to assess utilization and uptake.
There were 27 female patients that received IORT, 23 (85.2%) of which required no further radiotherapy. Three (7.4%) patients had positive axillary lymph nodes and/or positive margins requiring subsequent WBRT. One patient (3.7%) developed an in-breast recurrence distant from the lumpectomy site 23 months after IORT. Ten patients (37.0%) developed a postoperative complication, including 5 seromas and 6 wound complications (superficial infections and/or wound necrosis). Overall, in the 46-month study period, IORT accounted for only 6.4% of 423 operations. Still, 27 of 29 (93.1%) patients who met eligibility criteria for IORT underwent the procedure.
Although IORT comprised only 6.4% of all cases due to higher rates of mastectomy rates and advanced disease in our population, there was a high uptake of IORT among patients who met eligibility criteria for the procedure. Major complication rates of IORT were low, and most patients successfully completed radiotherapy in 1 intraoperative dose.
对于早期乳腺癌低危患者,保乳术后可采用术中放疗(IORT)进行单次剂量放疗,而无需进行传统的 6 周全乳放疗(WBRT)。本研究旨在分析一家社区医院 IORT 项目的应用情况。
对 2014 年 9 月至 2018 年 6 月期间所有接受 IORT 的患者进行回顾性分析。分析患者的人口统计学、肿瘤特征和 IORT 结果。通过确定接受 IORT 的患者比例来评估其利用率和应用情况。
共 27 例女性患者接受 IORT,其中 23 例(85.2%)无需进一步放疗。3 例(7.4%)患者腋窝淋巴结阳性和/或切缘阳性,需行后续 WBRT。1 例(3.7%)患者在 IORT 后 23 个月发生了距保乳手术部位较远的局部复发。10 例患者(37.0%)发生术后并发症,包括 5 例血清肿和 6 例伤口并发症(浅表感染和/或伤口坏死)。在 46 个月的研究期间,IORT 仅占 423 例手术的 6.4%。尽管如此,在符合 IORT 适应证的 29 例患者中,有 27 例接受了该手术。
尽管由于我们人群中乳房切除术率较高且疾病进展较晚,IORT 占所有病例的比例仅为 6.4%,但符合 IORT 适应证的患者对 IORT 的接受程度较高。IORT 的主要并发症发生率较低,大多数患者成功地在单次术中剂量内完成了放疗。